Nexus Company News Massalia Therapeutics Wins the i-Lab 2025 Competition to Advance its Sole-in-Class SANF-Targeting Platform for Fibrosis, Neovascularization & Treatment-resistant Cancers
Nexus Company News Roca Therapeutics Secures First-ever EMA Recognition of Radiation Maculopathy as Distinct Indication – and Orphan Drug Designation